Richard Drexler, Franz L Ricklefs, Sharona Ben-Haim, Anna Rada, Friedrich Wörmann, Thomas Cloppenborg, Christian G Bien, Matthias Simon, Thilo Kalbhenn, Albert Colon, Kim Rijkers, Olaf Schijns, Valeri Borger, Rainer Surges, Hartmut Vatter, Michele Rizzi, Marco de Curtis, Giuseppe Didato, Nicoló Castelli, Alexandre Carpentier, Bertrand Mathon, Clarissa Lin Yasuda, Fernando Cendes, Poodipedi Sarat Chandra, Manjari Tripathi, Hans Clusmann, Daniel Delev, Marc Guenot, Claire Haegelen, Hélène Catenoix, Johannes Lang, Hajo Hamer, Sebastian Brandner, Katrin Walther, Jason S Hauptmann, Rosalind L Jeffree, Josua Kegele, Eliane Weinbrenner, Georgios Naros, Julia Velz, Niklaus Krayenbühl, Julia Onken, Ulf C Schneider, Martin Holtkamp, Karl Rössler, Andrea Spyrantis, Adam Strzelczyk, Felix Rosenow, Stefan Stodieck, Mario A Alonso-Vanegas, Jörg Wellmer, Tim Wehner, Lasse Dührsen, Jens Gempt, Thomas Sauvigny
OBJECTIVE: Benchmarking has been proposed to reflect surgical quality and represents the highest standard reference values for desirable results. We sought to determine benchmark outcomes in patients after surgery for drug-resistant mesial temporal lobe epilepsy (MTLE). METHODS: This retrospective multicenter study included patients who underwent MTLE surgery at 19 expert centers on five continents. Benchmarks were defined for 15 endpoints covering surgery and epilepsy outcome at discharge, 1 year after surgery, and the last available follow-up...
February 24, 2024: Epilepsia